Chief Business Development Officer
CurrentAs the CBDO at HQ Science Ltd, I drive the strategic growth and market expansion of cutting-edge molecular diagnostic solutions. My focus is on building partnerships, creating scalable go-to-market strategies, and positioning HQ Science as a leader in AI-powered point-of-care diagnostics. I oversee key initiatives to bring revolutionary technologies, like the Tachyon device, to global markets, ensuring accessibility, affordability, and precision in molecular testing.With a deep understanding of the healthcare industry, I collaborate with stakeholders, including CROs, healthcare providers, and public health organizations, to deliver innovative solutions tailored to diverse needs. My expertise lies in identifying opportunities, fostering collaborations, and driving adoption of advanced diagnostic tools that redefine patient care and research capabilities.